Where does Peptilogics's cap table come from?

Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Peptilogics's 4 recorded funding rounds.

Premier Alternatives

Peptilogics

Pittsburgh, PA · Founded 2013 · Privately Held (backing)

Developer of a therapeutic and drug discovery peptide platform designed to treat multidrug-resistant bacterial infections. Peptilogics is based in Pittsburgh, PA and was founded in 2013. It was valued at $150 million at its later-stage round in May 2025, the last priced event on record. It has raised $195 million across 4 recorded rounds; the latest was a $35.8 million early-stage round in Dec 2020.

PMV mark · valuation

$150.0M

Oct 2026

Priced at

its later-stage round

May 2025

Total raised

$194.8M

Last round

Early Stage VC

Dec 2020

Cap table — not yet on record

Peptilogics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.

Pro members can request priority coverage with a 48-hour turnaround.

Free account

More of Peptilogics with a free account

·The complete investor list: 30 names
·Watch Peptilogics: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Frequently asked about Peptilogics

Where does Peptilogics's cap table come from?: Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Peptilogics's 4 recorded funding rounds.